Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | REGN | ARGX | ||
| Company | Celgene Corp | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 108.01 | 741.59 | 885.45 | ||
| High | 108.59 | 746.05 | 887.60 | ||
| Low | 107.27 | 734.99 | 875.60 | ||
| Latest | 108.24 | 740.86 | 880.97 | ||
| Change | +0.11 | -5.94 | -8.52 | ||
| % Change | +0.10% | -0.80% | -0.96% | ||
| Volume | 191,230,496 | 324,392 | 140,426 | ||
| 20-Day Average Volume | 16,188,930 | 1,103,323 | 333,151 | ||
| Previous Close | 108.13 | 746.80 | 889.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 734.80 | 908.30 | ||
| 20-Day Raw Stochastic | 63.25% | 49.35% | 12.46% | ||
| 20-Day Relative Strength | 64.69 | 59.18 | 54.06 | ||
| Weighted Alpha | +46.30 | +14.35 | +56.00 | ||
| Today's Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | +2.70% since 12/05/25 | -1.85% since 12/05/25 | ||
| Low | 107.27 on 11/20/19 | 691.86 on 12/09/25 | 877.40 on 12/12/25 | ||
| High | 110.53 on 11/14/19 | 753.61 on 12/11/25 | 917.71 on 12/08/25 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | +8.22% since 11/12/25 | -0.60% since 11/12/25 | ||
| Low | 102.40 on 10/21/19 | 679.93 on 11/13/25 | 877.40 on 12/12/25 | ||
| High | 110.70 on 11/13/19 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | +31.75% since 09/12/25 | +16.94% since 09/12/25 | ||
| Low | 93.41 on 08/23/19 | 541.00 on 10/13/25 | 698.92 on 09/25/25 | ||
| High | 110.70 on 11/13/19 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | +41.38% since 06/12/25 | +50.75% since 06/12/25 | ||
| Low | 89.08 on 07/23/19 | 503.25 on 06/18/25 | 510.05 on 06/30/25 | ||
| High | 110.70 on 11/13/19 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 78,487,928 | 54,765,008 | ||
| Shares Outstanding, K | 711,714 | 105,099 | 61,569 | ||
| Annual Sales | 15,281,000,000 | 14,202,000,000 | 2,252,040,000 | ||
| Annual Net Income | 4,046,000,000 | 4,412,600,000 | 833,040,000 | ||
| Last Quarter Sales | 4,520,000,000 | 3,754,300,000 | 1,151,340,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 1,460,000,000 | 344,260,000 | ||
| 60-Month Beta | 1.41 | 0.37 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 11.83 on 10/28/25 | 5.18 on 10/30/25 | ||
| Latest Earnings Date | 01/30/20 | 02/03/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | 0.880 on 11/20/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/20/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 19.80 | 68.05 | ||